InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: Jesspro post# 12435

Saturday, 01/01/2022 11:26:31 PM

Saturday, January 01, 2022 11:26:31 PM

Post# of 14947
Yes that is a very interesting second generation oncolytic virus loaded with very important I/O elements. I can see it being used along with a systemic(SOFUSA delivered?) anti-CTLA4. And in the latest list of Mabs I noted that Sorrento now lists an anti-CTLA4. A second generation anti-CTLA4 can be powerful!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News